NCT02672267View on ClinicalTrials.gov

A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Myocardial Infarction

Interventions

BIOLOGICAL

Stem cells

human Allogeneic Low Oxygen mesenchymal stem cells; Ischemia tolerant

OTHER

Placebo

Lactated Ringer's Solution

Trial Locations (1)

010000

National Research Medical Center, Astana

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

lead

Altaco XXI, LLP

OTHER

NCT02672267 - A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction | Biotech Hunter | Biotech Hunter